Bio-Techne (TECH) Share-based Compensation (2009 - 2026)
Bio-Techne (TECH) posted quarterly Share-based Compensation of $40.8 million for Q1 2026, up 116471.43% year-over-year from N/an in Q1 2025, and up 10838.34% quarter-over-quarter from $373000.0 in Q4 2025.
Powered by 
Analysis
Bio-Techne (TECH) Share-based Compensation (2009 - 2026) Analysis & Trends
Bio-Techne's Share-based Compensation history runs 18 years deep, the most recent figure standing at $40.8 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 116471.43% year-over-year to $40.8 million; the TTM figure through Mar 2026 stood at $40.8 million (up 4711.32% YoY), while the FY2025 annual figure was $40.8 million, up 14.06% from the prior year.
- Share-based Compensation for Q1 2026 stood at $40.8 million, up from $373000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $40.8 million in Q1 2026, with the low at -$12.4 million in Q2 2023.
- The 5-year median for Share-based Compensation is $113000.0 (2023), against an average of $3.4 million.
- The sharpest annual moves came in 2023 and 2026: Share-based Compensation slumped 153.99% in 2023, then surged 116471.43% in 2026.
- Bio-Techne's Share-based Compensation stood at $333000.0 in 2022, then increased by 2.1% to $340000.0 in 2023, then advanced by 9.71% to $373000.0 in 2024, then changed by 0.0% to $373000.0 in 2025, then jumped by 10838.34% to $40.8 million in 2026.
- Business Quant data shows TECH's Share-based Compensation at $40.8 million in Q1 2026, $373000.0 in Q4 2025, and -$2000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 120.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 277.20 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 137.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 86.63 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 5.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.23 Mn |
| Mar 31, 2026 | 40.80 Mn |
| Dec 31, 2025 | 373,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | 4.55 Mn |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 373,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 7.52 Mn |
| Mar 31, 2024 | 80,000.00 |
| Dec 31, 2023 | 340,000.00 |
| Sep 30, 2023 | 112,000.00 |
| Jun 30, 2023 | -2.09 Mn |
| Mar 31, 2023 | 113,000.00 |
| Dec 31, 2022 | 333,000.00 |
| Sep 30, 2022 | 97,000.00 |
| Jun 30, 2022 | 12.62 Mn |
| Mar 31, 2022 | 25,000.00 |
| Dec 31, 2021 | 267,000.00 |
| Sep 30, 2021 | 341,000.00 |